Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

BCS
Home/The Filing Wire/CTT PHARMACEUTICAL HOLDINGS, INC./ 10-K

Annual Report · 10-K

CTT PHARMACEUTICAL HOLDINGS, INC.

CTTHOTCEQUITYCurrent

Annual Report

Filed Apr 14, 2015Accepted Apr 14, 2015, 5:26 PM EDTCIK 1035422Accession 0001553350-15-000347
View company →Permanent SEC source ↗
Share

Company context

CTT Pharmaceutical Holdings, Inc. is a pharmaceutical technology company specializing in oral drug delivery systems designed to provide rapid onset, enhanced patient convenience, and efficient absorption. The Company’s patented micelle based thin film platform is intended to offer a novel alternative to traditional dosage forms across pharmaceutical, therapeutic, and nutraceutical markets. CTT is focused on integrating scientific validation, scalable manufacturing, and regulatory preparedness to support long-term growth and product innovation.

Current securities

CTTHOTC · EQUITY · Current

Recent company filings

  1. 4/A filingSep 29, 2026
  2. 4 filingSep 28, 2026
  3. Entry into a Material Definitive Agreement · Other EventsSep 23, 2026
  4. 4 filingSep 22, 2026
  5. 10-Q filingSep 17, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.